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ABSTRACT
This experiment was performed in order to clarify the effect of acute phase response following the 
induction of endotoxemia by Escherichia coli serotype O55:B5 and regarding its comparative treatment with 
dexamethasone and fl unixin meglumine in the Iranian fat-tailed sheep. Fifteen, clinically healthy, one-year 
old Iranian fat-tailed ewes were randomly assigned into three equal (n = 5) experimental groups, comprising 
of a control group, and a Dexa and a Flnx group. Lipopolysaccharide from Escherichia coli serotype O55:B5 
was administered intravenously at 20 μg/kg. All experimental groups underwent intravenous fl uid therapy 
for 120 minutes after lipopolysaccharide injection. 180 minutes after lipopolysaccharide, Dexamethasone (in 
Dexa group at 1 mg/kg) and  fl unixin meglumine (in Flnx group at 2.2 mg/kg) were injected, along with the 
intravenous fl uid for 60 minutes. The control group received only lipopolysaccharide and was treated with an 
intravenous fl uid without any drug. The researchers collected blood samples from all the ewes and assayed 
separated sera for serum acute phase proteins (serum amyloid A and haptoglobin) and infl ammatory cytokines 
(tumor necrosis factor-alpha and interferon-gamma). In all experimental groups there a rapid increase was 
noted in the amount of acute phase proteins and infl ammatory cytokines after endotoxemia induction (P<0.05). 
At the same time, there were no signifi cant differences in the amount of acute phase proteins and infl ammatory 
cytokines concentration for groups treated with dexamethasone and fl unixin meglumine (P>0.05). The fi ndings 
also revealed that immediate intravenous administration of dexamethasone and fl unixin meglumine reduced and 
controlled the acute phase response in sheep endotoxemia due to Escherichia coli serotype O55:B5. 
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Introduction
The acute phase response (APR) is a set of immediate host infl ammatory reactions 
that counteract the challenges of endotoxemia. APR isolates and counteracts pathogens, 
prevents further pathogen entry by minimizing tissue damage and encourages repair 
processes; it therefore permits host homeostatic mechanisms rapidly to re-establish 
normal physiological functions (KUSHNER, 1982; BAUMANN and GAULDIE, 1994). APR 
induces an infl ammatory mediator cascade, accompanied by local vascular and systemic 
multiorgan effects. Systemic multiorgan effects cause biosynthetic changes, prominently 
in the liver, altering the profi le of circulating plasma proteins. One of the most important 
experiments, which intensively studied systemic responses to an acute infl ammatory 
stimulus, was the study of alterations in the hepatic biosynthetic profi le of acute phase 
proteins (APPs) (STEEL and WHITEHEAD, 1994; GABAY and KUSHNER, 1999). APPs and 
their changes due to different infl ammatory and non-infl ammatory conditions have been 
studied in detail in many animal species (KANEKO, 1997; ECKERSALL, 2000; PETERSEN 
et al., 2004; MURATA et al., 2004; MURATA, 2007). Infl ammatory cytokines, such as 
tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ), are involved in the 
systemic infl ammation and are the members of a molecule group that stimulate the APR. 
Their sensitivity in the evaluation of APPs and infl ammatory cytokines for diagnosis of a 
disease is higher than hematological and clinical tests. Hematological factors show such 
great variance in different stages of infl ammatory diseases, and clinical tests diagnose 
the diseases when it has already developed (NAZIFI et al., 2008). Knowledge regarding 
the amount of APR in sheep undergoing endotoxemia and following its treatment is rare. 
Therefore, the present experiment was designed to clarify the amount of APR following 
 the induction of endotoxemia by Escherichia coli serotype O55:B5 and concerning its 
comparative treatment with dexamethasone and fl unixin meglumine in Iranian fat-tailed 
sheep. 
Materials and methods 
Animals. The present experiment was performed after receiving approval from the 
Ethics Committee of the School of Veterinary Medicine, Shiraz University. Fifteen, 
clinically healthy, one-year old Iranian fat-tailed ewes (25 ± 1.5 kg bodyweight) were 
randomly selected in April 2011. All the animals were kept in the Research Barn of 
the Agricultural College of Shiraz University, Shiraz (latitude 29° 32’ N and longitude 
52° 35’ E, 1810 m above sea level), in the south of Iran. Four weeks before beginning 
our experiments, each sheep was given albendazole (15 mg/kg, orally; Dieverm®600, 
Razak Pharmaceutical Co, Tehran, Iran) and ivermectin (0.2 mg/kg, subcutaneously; 
Erfamectin®1%; Erfan Pharmaceutical Co, Tehran, Iran) in order to control its internal 
and external probable parasites. All the ewes were kept in open-shed barns, with free 
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access to water and shade. The rations prepared were mainly alfalfa hay, corn silage, corn 
and barley. Subsequently, the ewes were assigned randomly into 3 equal experimental (n 
= 5) groups, that is a Control group, and Dexa and Flnx groups.
Chemicals and drugs. Phenol extracted lipopolysaccharide (LPS) from Escherichia 
coli serotype O55:B5 (Sigma-Aldrich®; product NO. L2880) was used to induce 
endotoxemia in ewes at 20 μg/kg. Until it was used, this endotoxin was diluted in sterile 
phosphate-buffered saline (PBS) and divided into 15 equal doses, each containing 
500 μg endotoxin and stored at -80°C. In each experiment, one dose was thawed and 
infused intravenously as described below. Dexamethasone (Vetacoid® 0.2%, Aburaihan 
Pharmaceutical Co., Tehran, Iran) and fl unixin meglumine (Meganix® 5%, Erfan 
Pharmaceutical Co., Tehran, Iran) were infused intravenously as described in the 
experimental procedures. The intravenous fl uid used in this experiment was dextrose 5% 
plus sodium chloride 0.45% (Shahid Ghazi Pharmaceutical CO., Tabriz, Iran).
Experimental procedures
Induction and treatment of endotoxemia. The schematic diagram of our experimental 
design is represented in Fig. 1. A 16 gauge 5.1 cm catheter was secured in the left jugular 
vein and used for blood sampling, endotoxin and drug infusions. All fi fteen ewes were 
examined clinically before the LSP injection and 1, 2, 3, 4, 5, 6 and 24 hours after it. 
The clinical parameters monitored during experiment include: rectal temperature, heart 
and respiratory rates, mucous membrane color, capillary refi ll time, appetite and fecal 
consistency. Thawed LPS (500 μg) was diluted in 250 milliliters of normal saline and 
infused intravenously at the rate of 10 mL/kg/hr. After LPS injection, intravenous fl uid 
therapy was performed for all experimental groups over 120 minutes, by dextrose 5% 
plus sodium chloride 0.45% at the rate of 20 mL/kg/hr. Dexamethasone (in Dexa group 
at 1 mg/kg) or fl unixin meglumine (in Flnx group at 2.2 mg/kg) was used at 180 minutes 
after LPS injection, along with the intravenous fl uid over 60 minutes. The control group 
received LPS and was treated only with intravenous fl uid without any drugs. To prevent 
hypoglycemia, blood glucose was monitored in all animals, using a rapid response 
glucose meter device (Accucheck Active®, Roche, Germany). 
Blood sampling and serological assays. Blood samples were collected from all ewes 
through the fi xed catheter before and 1, 2, 3, 4, 5, 6 and 24 hours after LPS injection in 
plain tubes. Immediately after collection, sera were separated by centrifugation (for 10 
minutes at 3,000×g) and stored at -22 °C until assayed. 
Haptoglobin (Hp) was measured according to prevention of hemoglobin peroxidase 
activity, which is directly proportional to the amount of Hp. The analytical sensitivity 
of this test in serum has been determined as 0.0156 mg/mL for Hp by the manufacturer 
(Tridelta Development Plc, Wicklow, Ireland). Serum amyloid A (SAA) was measured 
by a solid phase sandwich ELISA. The analytical sensitivity of this test in serum has 
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been determined as 0.3 μg/mL for SAA by the manufacturer (Tridelta Development Plc, 
Wicklow, Ireland). TNF-α and IFN-γ were also measured by a solid phase sandwich 
ELISA (AbC 606 and AbC 607, respectively; Votre fournisseur AbCys S.A. Paris, France).
Fig. 1. Schematic diagram of the present experimental design. Lipopolysaccharide (LPS) was 
injected at hour zero and intravenous fl uid therapy was commenced 2 hrs later in Iranian fat 
tailed sheep. Dexamethasone and fl unixin meglumine were infused via fl uid between hours 3 
and 4, over 60 minutes in the Dexa and Flnx groups, respectively. Venous blood sampling was 
performed at all demonstrated times.
Statistical analyses. Data were described as mean ± standard error of mean (SEM). 
We performed statistical analysis using one-way ANOVA, with an LSD post-hoc test to 
compare mean concentrations of the different serological factors between the different 
experimental groups, within similar times. The paired sample t-test was used to determine 
differences between the experimental groups at two different times, using SPSS software 
(SPSS for Windows, version 11.5, SPSS Inc, Chicago, Illinois). The level of signifi cance 
was set at P<0.05.
Results
After endotoxemia induction, SAA and Hp elevated rapidly in both experimental 
groups (Fig. 2). These rapid elevations differed between hour zero and hour 3 (after 
which intravenous fl uid therapy commenced; P<0.05). For the control group, serum 
concentrations of SAA a t hours 6 and 24 was higher than the other two experimental 
groups at the same hours (P<0.05; Fig. 2A). I n the control group, serum Hp concentrations 
at hours 4, 5, 6 and 24 hours were signifi cantly higher than in the Dexa and Flnx groups 
at the same times (P<0.05; Fig. 2B). There were no signifi cant differences seen between 
serum APP concentrations in the Dexa and Flnx groups at similar times (P>0.05). There 
was also no signifi cant difference seen in the concentrations of different factors between 
hours zero and 24 in either Dexa or the Flx group (P>0.05).
A rapid elevation of serum TNF-α and IFN-γ was detected after endotoxemia 
induction in the experimental groups (Fig. 3). There were signifi cant differences between 
the elevation of TNF-α at hour 3 and its base line levels at hour zero (P<0.05; Fig. 3A). 
The same pattern was observed for IFN-γ, also. After hour 4, serum TNF-α and IFN-γ 
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Fig. 2. Serum amyloid A (SAA, A) and haptoglobin (Hp, B) alterations due to experimental 
endotoxemia in 3 experimental groups of Iranian fat-tailed sheep (n = 5). a, b different letters show 
signifi cant differences in similar hrs between groups (P<0.05).
concentrations in the control group were signifi cantly higher than in the Dexa and Flnx 
groups (P<0.05). There no signifi cant differences were seen between serum infl ammatory 
cytokine concentrations in the Dexa and Flnx groups at the same hours (P>0.05). Serum 
concentrations of TNF-α and IFN-γ at hour 24 were not signifi cantly different from the 
base line levels at hour zero in both treatment groups (P>0.05). 
All sheep were alive and healthy after all experiments. 
306 Vet. arhiv 83 (3), 301-312, 2013
A. A. Chalmeh et al.: Treatment of acute phase response following experimental endotoxemia in sheep
Discussion
APPs are a group of blood proteins whose concentrations change in animals subjected 
to external or internal challenges, such as infection, infl ammation, surgical trauma or 
stress (MURATA et al., 2004; GRUYS et al., 2005). APPs and their alterations due to different 
infl ammatory and non infl ammatory conditions have been studied intensively in many 
animal species (MURATA et al., 2004; MURATA, 2007). No study was found in literature 
regarding the APP profi le in endotoxemia due to Escherichia coli serotype O55:B5 and 
its treatment in Iranian fat-tailed sheep. 
Fig. 3. Tumor necrosis factor-alpha (TNF-α, A) and interferon-gamma (IFN-γ, B) alterations due 
to experimental endotoxemia in 3 experimental groups of Iranian fat-tailed sheep. a, b different 
letters show signifi cant differences at similar hrs between groups (P<0.05).
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SAA and Hp, as well as other APPs, have been suggested as markers of stress in 
animals (ARTHINGTON et al., 2003; HICKEY et al., 2003; PINEIRO et al., 2007). SAA is 
an apolipoprotein of high-density lipoprotein and is considered to be one of the major 
APPs in vertebrae (NAKAYAMA et al., 1993; GRUYS et al., 1994; HUSBY et al., 1994). 
Determination and evaluation of SAA has indicated that this APP could be a valuable 
factor in the diagnosis of infections (ALSEMGEEST et al., 1994). LEHTOLAINEN et 
al. (2004) described that during experimental endotoxin-induced mastitis in cattle, 
SAA concentrations increased both in serum and milk. The results of this experiment 
showed that SAA elevated rapidly and signifi cantly after endotoxemia induction in all 
experimental groups (P<0.05; Fig. 2A). SAA refl ected the course of infl ammation and 
its level correlated with the clinical severity of the infl ammation. SAA has the greatest 
function in bacterial and pyogenic infections, and increases in common infectious diseases 
(NAZIFI et al., 2008). Elevated serum SAA levels have been found following infl ammation 
and also under conditions unrelated to infl ammation, such as physical stress (MURATA et 
al., 2004). LOMBORG et al. (2008) demonstrated marked SAA responses in healthy adult 
cattle after they were subjected to complex stressors (transportation, tie stall housing, 
slippery fl oors, and social isolation). At the beginning of infl ammatory reactions or after 
an injury, SAA concentrations increase rapidly. However, the underlying mechanism that 
causes the increase in SAA has not been clearly defi ned (NAZIFI et al., 2008). Although 
the serum concentrations of SAA decreased signifi cantly in the Flnx and Dexa groups 
(P<0.05), we found no signifi cant differences between the effi cacy of dexamethasone and 
fl unixin meglumine in decreasing SAA at similar times. 
Hp is an alpha2-globulin synthesized in the liver and another major APP in numerous 
species of productive and companion animals (FELDMAN et al., 2000). In ruminants, the 
level of circulating Hp is negligible in normal animals, but increases over 100-fold with 
immune stimulation (CONNER et al., 1989). Many studies have indicated the signifi cance 
of Hp as a clinically useful parameter for evaluation of the occurrence and severity of 
infl ammatory diseases in sheep (PFEFFER and ROGERS, 1989; SKINNER and ROBERTS, 
1994). Determination and evaluation of serum Hp have shown that this protein could 
be valuable in the diagnosis of infection and infl ammatory conditions. Serum Hp is 
most helpful when used together with herd history, clinical signs and laboratory tests 
(ALSEMGEEST et al., 1994). In the present experiment, following intravenous endotoxin 
infusion, rapid and signifi cant elevation in serum concentrations of Hp was observed in 
all ewes (P<0.05; Fig. 2B).
TNF-α is a member of a group of cytokines that stimulate the APR, and it is involved in 
systemic infl ammation. The primary role of TNF-α is regulation of immune cells. TNF-α 
is able to induce apoptotic cell death and infl ammation, and to inhibit tumorigenesis and 
viral replication. It is produced by a broad variety of cell types, including lymphoid cells, 
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mast cells, endothelial cells, cardiac myocytes, adipose tissue, fi broblasts, and neuronal 
tissue. A large amount of TNF-α is released in response to endotoxins. In the liver, TNF-α 
stimulates APR, leading to an increase in APPs. The responses of endothelial cells to 
TNF-α include: structural rearrangement, production of neutrophil adherence proteins, 
expression of procoagulant activity, and down-regulation of thrornbomodulin (MOVAT, 
1987). TNF-α causes endothelial dysfunction and apoptosis, triggers procoagulant 
activity and fi brin deposition, and enhances nitric oxide synthesis in a variety of cells 
(SENGUPTA et al., 2008). Contributing to the infl ammatory changes that occur in many 
tissues during endotoxemia, neutrophils are activated and stimulated to adhere to the 
vascular endothelium by TNF-α (SATOMI et al., 1985). TNF-α has especially been amply 
involved in deleterious host responses (HEINZEL, 1990). Signifi cant (P<0.05) and rapid 
elevation of serum TNF-α was observed before commencing intravenous fl uid therapy 
in both the experimental groups. In the present experimental endotoxemia induction, 
marked and signifi cant depressions of TNF-α were observed in the Dexa and Flnx groups. 
No signifi cant differences were seen between dexamethasone and fl unixin meglumine in 
controlling elevated serum TNF-α and the two drugs clearly attenuated the APR, due to 
decreasing of TNF-α concentrations. 
IFN-γ is a dimerized soluble cytokine, that is the only member of the type II class of 
interferons. IFN-γ is a cytokine that is critical for innate and adaptive immunity against 
viral and intracellular bacterial infections. The importance of IFN-γ in the immune 
system stems from its ability to inhibit viral replication directly, and, most importantly, 
its immunostimulatory and immunomodulatory effects. IFN-γ is produced predominantly 
by natural killer and natural killer T cells as part of the innate immune response, and by 
CD4 and CD8 cytotoxic T lymphocyte effector T cells, once antigen-specifi c immunity 
develops. Endotoxin activates macrophage microbicidal effectors functions and stimulates 
the production of proinfl ammatory cytokines, such as IFN-γ (SCHRODER et al., 2004). In 
the present experiment, the results of the IFN-γ assay showed that the value of serum 
concentrations of this infl ammatory cytokine in the control group was signifi cantly higher 
than in the experimental groups after treatment (P<0.05; Fig. 3B). According to our 
fi ndings, dexamethasone and fl unixin meglumine effi ciently controlled the serum IFN-γ 
levels and there was no difference in the potency of the two drugs in this respect. 
Nonsteroidal anti-infl ammatory drugs (NSAIDs) have been used in general for the 
treatment of endotoxemia, because of their analgesic, anti-infl ammatory and antipyretic 
properties. NSAIDs overcome the production of cytokines and reduce the acute 
hemodynamic response to endotoxemia. Flunixin meglumine is the most commonly used 
type of NSAID in the treatment of endotoxemia in horses and cattle, and has remained 
the best choice for treatment of this condition. Flunixin meglumine also adjusts acute 
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hemodynamic changes commonly seen during endotoxemia, which may increase 
survival rates (RADOSTITS et al., 2007). The results of the present experiment showed 
that intravenous administration of fl unixin meglumine reduced the serum concentrations 
of APPs and infl ammatory cytokines, to near base line levels within 24 hours (Fig. 2). 
According to these fi ndings, it may be said that fl unixin meglumine can control APR 
in experimental endotoxemia induced by phenol extracted LPS from Escherichia coli 
serotype O55:B5 in Iranian fat-tailed sheep. 
Corticosteroids are used extensively for the treatment of endotoxemia and endotoxic 
shock. These drugs are less often administered to endotoxemic animals, as a result of 
a number of studies supporting the use of NSAIDs. Corticosteroids promote capillary 
endothelial integrity and tissue perfusion, decrease the activation of the complement 
and clotting cascade, decrease neutrophil aggregation, stabilize lysosomal membranes, 
protect against hepatic injury and improve survival rate. However, there are concerns 
about their use in septicemic animals, because they may cause immunosuppression 
(RADOSTITS et al., 2007). Dexamethasone is the most commonly used corticosteroid 
in endotoxemia. However, a review of literature revealed that corticosteroids are the 
most helpful therapeutically when given as a pretreatment in experimental endotoxemia 
situations (REYNOLDS et al., 2002). It is currently believed that corticosteroids, if 
they are to be clinically effective, must be given as early as possible to endotoxemic 
animals (RADOSTITS et al., 2007). Our fi ndings revealed that intravenous administration 
of dexamethasone, after endotoxemia induction by Escherichia coli serotype O55:B5 
and the appearance of APR, was effective to reduce serum concentrations of APPs and 
infl ammatory cytokines. 
It was concluded that immediate intravenous administration of dexamethasone 
and fl unixin meglumine, at 1 and 2.2 mg/kg, respectively, reduced and controlled 
APR in Escherichia coli serotype O55:B5 endotoxemic sheep. It was also concluded 
that there were no signifi cant differences between the effi cacy of dexamethasone and 
fl unixin meglumine in combating APR due to endotoxemia in Iranian fat-tailed sheep. 
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CHALMEH, A., K. BADIEI, M. POURJAFAR, S. NAZIFI: Odgovor akutne faze 
kod endotoksemije pokusno izazvane serovarom O55:B5 bakterije Escherichia coli 
i njezino liječenje deksametazonom i fluniksin megluminom u iranske masnorepe 
ovce. Vet. arhiv 83, 301-312, 2013.
SAŽETAK
Istraživanje je poduzeto s ciljem da se razjasni učinak odgovora proteina akutne faze nakon pokusno 
izazvane endotoksemije serovarom O55:B5 bakterije E. coli s obzirom na mogućnost njezina liječenja istodobno 
deksametazonom i fl uniksin megluminom u iranske masnorepe ovce. U pokus je bilo uzeto 15 klinički zdravih 
jednogodišnjh iranskih masnorepih ovaca, koje su bile nasumce podijeljene u tri skupine po pet, tj. kontrolnu 
te u pokusnu skupinu koja je dobivala deksametazon i skupinu koja je dobivala fl uniksin. Lipopolisaharid 
serovara O55:B5 bakterije Escherichia coli bio je primijenjen intravenski u količini 20 μg/kg. Sve životinje 
pokusnih skupina intravenski su dobile fi ziološku otopinu tijekom 120 minuta nakon davanja lipopolisaharida. 
180 minuta nakon davanja lipopolisaharida jednoj je pokusnoj skupini primijenjen deksametazon (1 mg/kg), a 
drugoj fl uniksin meglumin (2,2 mg/kg) intravenski u fi ziološkoj otopini tijekom 60 minuta. Ovcama kontrolne 
skupine bio je primijenjen samo lipopolisaharid i fi ziološka otopina primijenjena intravenski. Uzorci krvi bili 
su uzeti od svih ovaca, a serum je bio pretražen na proteine akutne faze (serumski amiloid A i haptoglobin) i 
upalne citokine (faktor tumorske nekroze alfa i interferon gama). U pokusnim skupinama ustanovljeno je naglo 
povećanje količine proteina akutne faze i upalnih citokina nakon izazivanja endotoksemije (P<0,05). Istodobno 
nije bila zabilježena značajna razlika u količini proteina akutne faze i koncentracije upalnih citokina za skupine 
koje su dobile deksametazon i fl uniksin meglumin (P>0,05). Rezultati su također pokazali da je brza intravenska 
primjena deksametazona i fl uniksin meglumina oslabila odgovor proteina akutne faze kod endotoksemije ovaca 
izazvane serovarom O55:B5 bakterije Escherichia coli.
Ključne riječi: endotoksemija, odgovor akutne faze, deksametazon, fl uniksin meglumin, iranska 
masnorepa ovca
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